BiotechTube
Home/Akros Pharma/Timothy J. Babcock, Esq.
TJ

Timothy J. Babcock, Esq.

Vice President, Intellectual Property

Akros Pharma

Therapeutic Areas

Autoimmune DiseasesMetabolic DisordersCardiovascular DiseasesNeurodegenerative Diseases

Akros Pharma Pipeline

DrugIndicationPhase
JTE-051Autoimmune diseases, Allergic diseasesPhase2
JTT-662Type 2 diabetes mellitusPhase1
JTT-861Chronic heart failurePhase2
JTC-064Neurodegenerative diseasePhase1
JTV-161Pulmonary arterial hypertensionPhase1
JTE-162Autoinflammatory/Autoimmune diseasesPhase1
JTC-262Neurodegenerative diseasePhase1
JTV-263Peripheral artery diseasePhase1

Leadership Team at Akros Pharma

TH
Teppei Higuchi
President & CEO
TN
Takanori Nemoto, M.S.
Vice President, Clinical Development
SP
Sudhakar Pai, Ph.D., FCP
Senior Director, Clinical Pharmacology
KP
Kala Patel, R.Ph.,RAC.
Senior Director, Regulatory Affairs
View full Akros Pharma profile